Literature DB >> 3410953

Serratia plymuthica osteomyelitis following a motorcycle accident.

R Zbinden1, R Blass.   

Abstract

Serratia plymuthica was isolated from the sinus tract and from the infected bone in a case of chronic osteomyelitis following an accident of a motorcyclist. This is the second case in which S. plymuthica was a significant pathogen. Previously, a case of S. plymuthica sepsis associated with infection of a central venous catheter was described.

Entities:  

Mesh:

Year:  1988        PMID: 3410953      PMCID: PMC266623          DOI: 10.1128/jcm.26.7.1409-1410.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

Review 1.  The genus Serratia.

Authors:  P A Grimont; F Grimont
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

Review 2.  Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens.

Authors:  J J Farmer; B R Davis; F W Hickman-Brenner; A McWhorter; G P Huntley-Carter; M A Asbury; C Riddle; H G Wathen-Grady; C Elias; G R Fanning
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

3.  Serratia plymuthica sepsis associated with infection of central venous catheter.

Authors:  H W Horowitz; R B Nadelman; K G Van Horn; S E Weekes; L Goyburu; G P Wormser
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

4.  Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B.

Authors:  W H Traub
Journal:  Chemotherapy       Date:  1982       Impact factor: 2.544

5.  Diagnostic value of sinus-tract cultures in chronic osteomyelitis.

Authors:  P A Mackowiak; S R Jones; J W Smith
Journal:  JAMA       Date:  1978-06-30       Impact factor: 56.272

6.  Isolation of Serratia plymuthica from a human burn site.

Authors:  R B Clark; J M Janda
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

  6 in total
  4 in total

1.  In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.

Authors:  P Hohl; J Lüthy-Hottenstein; J Zollinger-Iten; M Altwegg
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 2.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

3.  Report of six cases of human infection by Serratia plymuthica.

Authors:  P Carrero; J A Garrote; S Pacheco; A I García; R Gil; S G Carbajosa
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

4.  Nosocomial septicemia caused by Serratia plymuthica.

Authors:  D Domingo; A Limia; T Alarcón; J C Sanz; M C Del Rey; M López-Brea
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.